InvestorsHub Logo
Followers 1329
Posts 250477
Boards Moderated 53
Alias Born 12/07/2009

Re: None

Tuesday, 01/23/2018 11:38:23 AM

Tuesday, January 23, 2018 11:38:23 AM

Post# of 19151
Cytta was also drawn to CardioComm’s potential to add multiple bio-sign monitoring under their Class II medical device clearances and thereby potentially cover the EvrCare branded platform services under a SaMD classification. https://finance.yahoo.com/news/telemedicine-technology-joint-venture-announced-113000797.html

$CYCA


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYCA News